Lara Meisner, CLO of Bicara Therapeutics BCAX, has filed 0 purchases and 12 sales on the open market. The latest trade was on 02/02.

LM

LM

Lara Meisner

Chief Legal Officer

Company

Bicara Therapeutics BCAX

First filing

23/01/25

Trades

39 trades

Buys / sales

0 / 12

12-month net buying

No record

Last trade

02/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/09/29	25/10/01	33,807 sh	$14.75	$498,653.25	−100.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/09/15	25/09/17	15,829 sh	$11.49	$181,875.21	−100.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/06/16	25/06/18	15,829 sh	$10.43	$165,096.47	−100.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/03/14	25/03/18	79,146 sh2 trades	$12.90avg.	$1,021,203.74	−100.0%
Viridian Therapeutics, Inc.\DEVRDN	Open-market sale	23/06/15–23/06/16	23/06/20	2,296 sh2 trades	$28.02avg.	$64,342.83	−7.1%
Viridian Therapeutics, Inc.\DEVRDN	Open-market sale10b5-1 plan	23/06/02–23/06/06	23/06/06	7,500 sh3 trades	$24.82avg.	$186,136.24	−20.0%
Viridian Therapeutics, Inc.\DEVRDN	Open-market sale	23/03/09	23/03/10	29,971 sh	$29.07	$871,256.97	−100.0%
Viridian Therapeutics, Inc.\DEVRDN	Open-market sale	23/01/23	23/01/25	6,843 sh	$35.66	$244,021.38	−100.0%